Literature DB >> 1840763

Can buspirone induce rebound, dependence or abuse?

M Lader1.   

Abstract

Buspirone is a newer anxiolytic which differs chemically and pharmacologically from the benzodiazepines. The question as to whether buspirone can induce rebound, dependence, or abuse can be examined through a variety of clinical and control studies, as well as animal studies, together with meticulous follow-up of adverse reports. It is concluded that, on present evidence, the short-term use of buspirone is unlikely to be followed by rebound or long-term use through dependence; nor is abuse likely to be a problem.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1840763

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  7 in total

1.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.

Authors:  Theresa Winhusen; Kathleen T Brady; Maxine Stitzer; George Woody; Robert Lindblad; Frankie Kropp; Gregory Brigham; David Liu; Steven Sparenborg; Gaurav Sharma; Paul Vanveldhuisen; Bryon Adinoff; Eugene Somoza
Journal:  Contemp Clin Trials       Date:  2012-05-19       Impact factor: 2.226

Review 3.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 4.  Advances in non-nicotine pharmacotherapy for smoking cessation.

Authors:  L S Covey; M A Sullivan; J A Johnston; A H Glassman; M D Robinson; D P Adams
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

5.  Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

Authors:  Aimee L McRae-Clark; Nathaniel L Baker; Kevin M Gray; Therese K Killeen; Amanda M Wagner; Kathleen T Brady; C Lindsay DeVane; Jessica Norton
Journal:  Drug Alcohol Depend       Date:  2015-08-25       Impact factor: 4.492

6.  A placebo-controlled trial of buspirone for the treatment of marijuana dependence.

Authors:  Aimee L McRae-Clark; Rickey E Carter; Therese K Killeen; Matthew J Carpenter; Amy E Wahlquist; Stacey A Simpson; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2009-08-21       Impact factor: 4.492

7.  Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.

Authors:  Theresa M Winhusen; Frankie Kropp; Robert Lindblad; Antoine Douaihy; Louise Haynes; Candace Hodgkins; Karen Chartier; Kyle M Kampman; Gaurav Sharma; Daniel F Lewis; Paul VanVeldhuisen; Jeff Theobald; Jeanine May; Gregory S Brigham
Journal:  J Clin Psychiatry       Date:  2014-07       Impact factor: 4.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.